On Thursday, April 16 NEHI convened a virtual meeting on the policy steps needed to bring patient focus to value-based arrangements.
NEHI Vice President of Policy Research Tom Hubbard, facilitated a panel discussion with:
- Derek Asay, Senior Director, Government Strategy, Federal Accounts and Quality, Eli Lilly and Company
- Patrick Gleason, Senior Director of Health Outcomes, Prime Therapeutics ; Fellow and Director, Academy of Managed Care Pharmacy
- Shawn Bishop, former professional staff member, U.S. Senate Finance Committee
Discussion focused on how appropriate changes in federal policy could bring greater patient focus to value-based arrangements while respecting broader federal goals, such as the goals of the Medicaid Drug Rebate Program and enforcement of the Anti-Kickback Statute. The topics included:
- The role of VBAs as tools for arrangements that meet payer financial goals while ensuring timely access to therapy for patients
- Sharing VBA financial benefits with patients
- Lawmakers’ perceptions of current VBAs and the need to demonstrate patient benefits from VBAs
- Understanding how current Medicaid Best Price reporting constraints risk-sharing in VBAs, and consequent impact on patients
- The potential for greater application of VBAs to chronic disease treatments
- The need for supportive policy that encourages VBAs linked to non-traditional, patient-centered outcomes metrics, such as patient-reported outcomes metrics.